Evidence map›Paper›PMID 42646087›Full record

ArticleJournal of fungi (Basel, Switzerland)2026

Aflatoxin B

Ramón Asis, Marina L Fernandez, Gustavo Bonacci, Jose Debes, Jhon Prieto, Andre Boonstra, Domingo C Balderramo, Pablo A Romagnoli

Abstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ramón AsisDepartamento de Bioquímica Clínica-Centro de Investigación en Bioquímica Clínica e Inmunología (CIBICI), Facultad de Ciencias Químicas, Universidad Nacional de Córdoba-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Córdoba 5000, Argentina.
Marina L FernandezCentro de Investigación en Medicina Traslacional "Severo R. Amuchástegui" (CIMETSA-CONICET), Instituto Universitario de Ciencias Biomédicas de Córdoba (IUCBC), Córdoba 5000, Argentina.
Gustavo BonacciDepartamento de Bioquímica Clínica-Centro de Investigación en Bioquímica Clínica e Inmunología (CIBICI), Facultad de Ciencias Químicas, Universidad Nacional de Córdoba-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Córdoba 5000, Argentina.
Jose DebesDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Jhon PrietoCentro de Enfermedades Hepáticas y Digestivas (CEHYD), Bogotá 110111, Colombia.
Andre BoonstraDepartment of Gastroenterology and Hepatology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.ORCID 0000-0001-8607-1616
Domingo C BalderramoHospital Privado Centro Medico de Córdoba S.A. (HPCMC), Córdoba 5000, Argentina.ORCID 0000-0001-9598-2577
Pablo A RomagnoliCentro de Investigación en Medicina Traslacional "Severo R. Amuchástegui" (CIMETSA-CONICET), Instituto Universitario de Ciencias Biomédicas de Córdoba (IUCBC), Córdoba 5000, Argentina.ORCID 0000-0002-6328-9070

Funding

horizon 2020, European-Latin American ESCALON consortium 825510International Atomic Energy Agency D52044, Contract Number 25058
6 · The paper itself

Abstract

Aflatoxin B

Indexed as

AFB1-Lysine adductaflatoxin B1biomonitoringfood safetyhepatocellular carcinomaHPLC-MS/MSmycotoxinSouth America

Identifiers

PMID42646087
PMCPMC13514370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.